Case Report
BibTex RIS Cite

Acute cholecystitis developing as a result of verapamil intoxication

Year 2017, Volume: 34 Issue: 3, 213 - 215, 10.07.2018

Abstract

Calcium channel blockers are the drugs with the highest poisoning-related mortality. The most commonly seen finding in verapamil intoxication is hypotension, with other frequently encountered findings being bradycardia and atrioventricular block. It may also lead to potentially fatal complications such as non-cardiogenic pulmonary edema. Gastrointestinal symptoms such as nausea and vomiting are uncommon. This report describes a case brought to the emergency department with abdominal pain, in which cholecystitis was determined following tests performed when hypotension and bradycardia could not be explained, and in which it was learned that the patient had taken a high dose of verapamil with the aim of committing suicide.Cholecystitis as a result of verapamil intoxication has never previously been reported in the literature.

References

  • Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive over dose of sustained-release verapamil: a case report and review of literature. Am J MedSci 1995;310:258-263 Dargie H, Rowland E, Krikler D. Role of calcium antagonists in cardiovascular therapy. Br Heart J 1981;46:8–16 Kenny J. Treating over dose with calcium channel blockers. BMJ 1994;308:992-993 Kline JA, Leonova E Raymond RM. Benefical myocardial matabolic effects of insulin during verapamil toxicity in the anest hetized canine. CritCareMed 1995;23:1251-1263 Matsumori A, Nishio R, Nose Y. Calcium Channel Blockers Differentially Modulate Cytokine Production by Peripheral Blood Mononuclear Cells. Circ J 2010; 74: 567–571 Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker over doses: toxicity and treatment. AnnEmergMed 1993;22:196-200 Russell RP. Side effects of calcium channel blockers. Hypertension 1988;11:42–4 Sami Karti S, Ulusoy H, Yandi M, et al. Non-cardiogenic pulmonary oedema in the course of verapamil intoxication. Emerg Med J 2002;19:458-9 Shen H, Wiederhold MD, Ou DW. The suppression of macrophage secretion by calcium blockers and adenosine. Immunop harmacol Immunotoxicol 1995;17:301–309 Tanizaki Y, Akagi K, Lee KN, Townley RG. Inhibitory effect of nifedipine and cromolynsodium on skin reactions and 45Ca uptake and histamine release in rat mast cells induced by various stimulating agents. IntArchAllergyApplImmunol 1983;72:102–109
Year 2017, Volume: 34 Issue: 3, 213 - 215, 10.07.2018

Abstract

References

  • Ashraf M, Chaudhary K, Nelson J, Thompson W. Massive over dose of sustained-release verapamil: a case report and review of literature. Am J MedSci 1995;310:258-263 Dargie H, Rowland E, Krikler D. Role of calcium antagonists in cardiovascular therapy. Br Heart J 1981;46:8–16 Kenny J. Treating over dose with calcium channel blockers. BMJ 1994;308:992-993 Kline JA, Leonova E Raymond RM. Benefical myocardial matabolic effects of insulin during verapamil toxicity in the anest hetized canine. CritCareMed 1995;23:1251-1263 Matsumori A, Nishio R, Nose Y. Calcium Channel Blockers Differentially Modulate Cytokine Production by Peripheral Blood Mononuclear Cells. Circ J 2010; 74: 567–571 Ramoska EA, Spiller HA, Winter M, Borys D. A one-year evaluation of calcium channel blocker over doses: toxicity and treatment. AnnEmergMed 1993;22:196-200 Russell RP. Side effects of calcium channel blockers. Hypertension 1988;11:42–4 Sami Karti S, Ulusoy H, Yandi M, et al. Non-cardiogenic pulmonary oedema in the course of verapamil intoxication. Emerg Med J 2002;19:458-9 Shen H, Wiederhold MD, Ou DW. The suppression of macrophage secretion by calcium blockers and adenosine. Immunop harmacol Immunotoxicol 1995;17:301–309 Tanizaki Y, Akagi K, Lee KN, Townley RG. Inhibitory effect of nifedipine and cromolynsodium on skin reactions and 45Ca uptake and histamine release in rat mast cells induced by various stimulating agents. IntArchAllergyApplImmunol 1983;72:102–109
There are 1 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Surgery Medical Sciences
Authors

Süha Türkmen This is me

Publication Date July 10, 2018
Submission Date July 19, 2015
Acceptance Date October 21, 2015
Published in Issue Year 2017 Volume: 34 Issue: 3

Cite

APA Türkmen, S. (2018). Acute cholecystitis developing as a result of verapamil intoxication. Journal of Experimental and Clinical Medicine, 34(3), 213-215.
AMA Türkmen S. Acute cholecystitis developing as a result of verapamil intoxication. J. Exp. Clin. Med. July 2018;34(3):213-215.
Chicago Türkmen, Süha. “Acute Cholecystitis Developing As a Result of Verapamil Intoxication”. Journal of Experimental and Clinical Medicine 34, no. 3 (July 2018): 213-15.
EndNote Türkmen S (July 1, 2018) Acute cholecystitis developing as a result of verapamil intoxication. Journal of Experimental and Clinical Medicine 34 3 213–215.
IEEE S. Türkmen, “Acute cholecystitis developing as a result of verapamil intoxication”, J. Exp. Clin. Med., vol. 34, no. 3, pp. 213–215, 2018.
ISNAD Türkmen, Süha. “Acute Cholecystitis Developing As a Result of Verapamil Intoxication”. Journal of Experimental and Clinical Medicine 34/3 (July 2018), 213-215.
JAMA Türkmen S. Acute cholecystitis developing as a result of verapamil intoxication. J. Exp. Clin. Med. 2018;34:213–215.
MLA Türkmen, Süha. “Acute Cholecystitis Developing As a Result of Verapamil Intoxication”. Journal of Experimental and Clinical Medicine, vol. 34, no. 3, 2018, pp. 213-5.
Vancouver Türkmen S. Acute cholecystitis developing as a result of verapamil intoxication. J. Exp. Clin. Med. 2018;34(3):213-5.